Nuvama Q4 FY26 call: dividend, ESARs, FY27 plans

Key updates from Nuvama’s latest disclosures

Nuvama Wealth Management has published a set of updates around its Q4 FY26 earnings cycle, board actions, and investor engagement. The company’s audited results for the quarter and financial year ended March 31, 2026 were approved in a board meeting on May 11, 2026, followed by an earnings conference call held on May 12, 2026. Separately, the company also announced a trading window closure starting July 1, 2026, and introduced a new employee incentive scheme that is subject to shareholder approval.

Alongside these governance and compliance disclosures, management commentary referenced FY27 business priorities, including fundraising targets for new alternative funds and a timeline for a mutual fund licence. The stock price shown in the provided data was ₹1,932, up ₹83.9 or 4.54%.

Q4 FY26 results cycle and earnings call availability

Nuvama stated that the audio recording of its earnings conference call held on May 12, 2026 is available on the company’s website. The call discussed performance for the quarter and financial year ended March 31, 2026, and was accompanied by an investor presentation.

The company also listed multiple “past events” around the Q4 FY26 cycle, including the earnings release and board meeting dated May 11, 2026 and the earnings presentation dated May 12, 2026. These disclosures matter for investors tracking both audited numbers and management commentary, especially when the company is also planning new product launches and shareholder actions.

Interim dividend: amount, record date, and payout timeline

At the board meeting held on May 11, 2026, Nuvama approved its consolidated and standalone audited financial results and declared an interim dividend. The interim dividend was set at ₹14 per equity share (face value ₹2) for the financial year 2026-27.

The record date to determine dividend eligibility was Friday, May 15, 2026, and the company indicated the dividend would be paid on or before June 9, 2026. The events list in the provided data also mentions an ex-dividend date of May 15, 2026 for the ₹14 dividend.

Trading window closure from July 1, 2026

Nuvama announced the closure of its trading window as part of insider trading prevention procedures. The closure is effective from July 1, 2026, and will remain in place until 48 hours after the company files its Q1 FY27 results (for the quarter ended June 30, 2026).

This disclosure is typically relevant for employees and connected persons covered under the company’s code of conduct. For investors, it is primarily a compliance signal that the company is approaching a financial reporting window for Q1 FY27.

ESAR Scheme 2026: scope and shareholder approval route

The board approved the adoption of the “Nuvama Wealth Management Limited Employee Stock Appreciation Rights Scheme 2026.” As described in the provided text, the scheme is intended to reward, motivate, and retain talent.

The proposed scheme involves granting up to 1,37,00,000 ESARs (13.7 million). The approval is subject to members’ consent through a postal ballot. The data also mentions a remote e-voting window from July 3, 2026 to August 1, 2026, aligning with a shareholder approval process.

Internal auditor appointment for FY2026-27

In a board meeting held on May 19, 2026, Nuvama approved the appointment of M/s Protiviti India Member Private Limited as internal auditors for the financial year 2026-27.

Internal audit appointments are part of the company’s governance framework and typically support controls, risk management, and process reviews across business lines. The disclosure provides clarity on the audit firm engaged for the year.

Analyst and institutional investor meetings in June 2026

Nuvama announced a schedule of analyst and institutional investor meetings for June 2026. Company representatives were set to participate in:

• Nuvama India Conference 2026 (UK Edition) on June 8-9
• Goldman Sachs 2026 Asia Financials Corporate Day on June 22
• JM Financial India Finance Forum on June 23

The company indicated discussions would be based on the investor presentation for the quarter and financial year ended March 31, 2026.

FY27 business commentary: fund launches and operating metrics

Management commentary in the provided text outlined an FY27 outlook with specific fundraising targets in Asset Management. The company referenced three potential launches:

• A commercial real estate fund targeting ₹3,000 to ₹3,500 crore
• A pre-IPO private equity fund targeting ₹1,000 to ₹1,500 crore
• A private credit fund targeting ₹1,000 to ₹1,500 crore

The same outlook note stated that a mutual fund licence was expected in approximately two months.

In Wealth Management, management cited an expected 100 bps annual reduction in the cost-to-income ratio over the next 3 to 4 years. The driver mentioned was a targeted 25% revenue jump per relationship manager, linked to seniorisation and AI adoption.

In Asset Services, the plan included launching RTA and trusteeship services by mid-Q3, and management expectation was for yields to remain stable to potentially rising.

Board meeting trail and a Q3 FY26 reference

The provided data includes a BSE-sourced disclosure dated January 16, 2026 about a scheduled board meeting on January 23, 2026 to consider items including results for the quarter and nine months ended December 31, 2025.

It also lists board meeting dates for quarterly and audited results over FY25 and FY26, including May 28, 2025 for audited results and interim dividend, and multiple quarterly results meetings. Such a schedule is useful for investors mapping typical reporting cadence.

Key data table: dates, actions, and disclosures

Market references: stock move and brokerage note

The data snapshot shows Nuvama at ₹1,932, up ₹83.9 or 4.54%. It also lists a brokerage update stating Jefferies adjusted its price target to ₹1,840 from ₹1,600 and maintained a “Buy” rating.

These are external market references included in the provided material, alongside the company’s own disclosures on dividend, governance actions, and investor communication.

Q1 FY27: estimate vs official disclosure

The provided text includes a Q1 FY27 “Uniresearch” preview that projects revenue of ₹633 crore and PAT of ₹332 crore, both indicated as +50% year-on-year. It also provides the base numbers for Q1 FY26 as revenue of ₹422 crore and PAT of ₹221 crore.

The same section states that the Q1 results date was not yet officially announced and that such dates are typically disclosed through a board meeting notice on NSE or BSE portals after the quarter ends.

Conclusion

Nuvama’s latest set of updates around the Q4 FY26 earnings cycle combines shareholder payouts, compliance actions, and forward business commentary. The interim dividend of ₹14 per share, the trading window closure from July 1, 2026, and the ESAR Scheme 2026 proposal are the key governance and shareholder-facing items.

Next disclosures to watch, based on the company’s own timeline cues, include the Q1 FY27 results filing that will determine the reopening of the trading window, and the outcome of the postal ballot process linked to the ESAR scheme.